Autoimmune neutropenia is a condition in which the immune system produces antibodies that mistakenly target and destroy neutrophils, the white blood cells responsible for fighting bacterial and fungal infections. The result is an abnormally low neutrophil count that can look alarming on a blood test but, depending on the form, may cause surprisingly few problems. The condition behaves quite differently in young children than in adults, and the gap between what the lab numbers suggest and what actually happens clinically is one of the more counterintuitive aspects of the disease.
What Happens Inside the Body
Neutrophils are the most abundant type of white blood cell and serve as the immune system’s first responders to bacterial invasion. In autoimmune neutropenia, the body makes antibodies, primarily of the IgG class, that bind to specific proteins on the neutrophil surface. In most childhood cases, the target is a receptor known as FcγRIIIb, a protein found almost exclusively on neutrophils.1PubMed Central. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians Once antibodies latch onto a neutrophil, the cell gets flagged for destruction. Immune cells called macrophages then engulf and digest the tagged neutrophils, and complement proteins in the blood can also punch holes in them directly.2PubMed. The role of neutrophils in antibody-driven autoimmune cytopenias The net effect is that neutrophils are cleared from the bloodstream faster than the bone marrow can replace them, and the count drops.
A bone marrow biopsy in someone with autoimmune neutropenia often reveals something that seems contradictory at first glance: the marrow is actually working overtime, churning out extra neutrophil precursors. However, these developing cells may stall partway through their maturation, a pattern described as maturation arrest.3PubMed. Five cases of autoimmune neutropenia in infancy or early childhood So the problem is not that the marrow is failing to produce neutrophils. The marrow is trying to compensate, but the antibodies are destroying finished neutrophils faster than they appear and may also be interfering with the later stages of development inside the marrow itself.
Primary Autoimmune Neutropenia in Children
The most common form is primary autoimmune neutropenia of infancy, which typically shows up between about five and fifteen months of age, though cases as early as the first month of life have been documented.4PubMed. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases It is the leading cause of chronic neutropenia in children under about four years old. The condition tends to be discovered incidentally when a blood count is drawn during a routine infection, and the neutrophil number comes back strikingly low.
What makes this form distinctive is how well children do despite the numbers. In a large analysis of 240 cases, about 90% of children experienced only ordinary, benign infections despite having severely low neutrophil counts. The same study found that roughly 95% of children went into spontaneous remission, typically within seven to twenty-four months.5Blood. Diagnosis and Clinical Course of Autoimmune Neutropenia in Infancy: Analysis of 240 Cases A cohort from western Romania confirmed a similar picture: median age at onset was about seven and a half months, boys were affected roughly twice as often as girls, and while half the children needed at least one hospitalization, only three patients in the entire cohort developed serious infections.6PubMed Central. Primary autoimmune neutropenia of infancy and childhood in a cohort of patients from western Romania
The reassuring natural history means that most children with primary autoimmune neutropenia simply outgrow it. The antibodies eventually fade, neutrophil counts normalize, and no lasting damage is done. For families, the hardest part is often the waiting period, knowing that their child’s blood count is technically in a dangerous range while being told to expect everything to turn out fine.
Secondary Autoimmune Neutropenia in Adults
Adults can develop autoimmune neutropenia too, but the picture is different. Rather than appearing on its own as a self-limiting immune glitch, neutropenia in adults usually rides along with another autoimmune or lymphoproliferative condition.7PubMed Central. Primary and secondary autoimmune neutropenia This is called secondary autoimmune neutropenia, and the underlying conditions include lupus, rheumatoid arthritis (especially the variant known as Felty’s syndrome), certain viral infections, medications, and lymphomas.
Felty’s syndrome is a classic example. It involves the combination of seropositive rheumatoid arthritis, an enlarged spleen, and neutropenia, and the neutropenia can be severe enough to cause recurrent bacterial infections.8PubMed. Management of autoimmune neutropenia in Felty’s syndrome and systemic lupus erythematosus Lupus is another frequent companion; neutropenia is common enough in lupus that it is included in the formal classification criteria for the disease. In these cases, treating the underlying autoimmune condition often improves the neutrophil count as well, because the antibody production is being driven by the broader immune dysregulation.
Primary autoimmune neutropenia does occur in adults, but it is considerably rarer than in children and poses more of a diagnostic challenge. When adults present with isolated neutropenia and no obvious autoimmune or malignant cause, clinicians have to work harder to confirm that antibodies are responsible rather than something else entirely.
What the Infections Actually Look Like
One of the most common fears for anyone diagnosed with neutropenia is overwhelming infection, and understandably so. Neutrophils are central to fighting bacteria and fungi, so logic suggests that losing them should be dangerous. In practice, autoimmune neutropenia, especially the primary childhood form, is far less risky than its lab values imply.
A large French retrospective study tracking children with autoimmune neutropenia found that the infections they experienced were overwhelmingly the same respiratory and viral illnesses that hit all young children. Serious bacterial or fungal infections were essentially absent from the cohort. The incidence of severe infection was just 0.003 per patient-year, and the one severe event in the study occurred in a child who was immunocompromised for other reasons.9Archives of Disease in Childhood. Analysis of infectious complications in paediatric autoimmune neutropenia: a French nationwide retrospective cohort study Interestingly, in more than half of infection episodes, neutrophil counts were still very low, suggesting the body has backup mechanisms for fighting infection even when neutrophils are depleted.
In adults with chronic neutropenia, the infection pattern tends to involve upper respiratory infections, gum disease, mouth ulcers, and skin infections.10PubMed Central. An update on the diagnosis and treatment of chronic idiopathic neutropenia Pneumonia is the most common of the severe infections, but even that is relatively unusual in the autoimmune form specifically. The disconnect between lab severity and clinical mildness is one of the defining features of this condition and an important reason why aggressive treatment is not always necessary.
How It Is Diagnosed
Diagnosing autoimmune neutropenia requires more than just documenting a low neutrophil count. The core challenge is proving that the low count is caused by antibodies rather than by a bone marrow production problem, a drug side effect, or a genetic syndrome.
The standard approach involves testing for antineutrophil antibodies, but this is trickier than testing for many other autoantibodies. Neutrophils are fragile, short-lived cells that easily activate during handling, which can produce false results. Several specialized assays exist. One flow-cytometry-based method that detects both IgG and IgM antibodies bound directly to the patient’s neutrophils has shown strong discriminatory power, with very high sensitivity and specificity in distinguishing autoimmune neutropenia from other causes of low counts.11PubMed. Diagnosis of autoimmune neutropenia by neutrophil-bound IgG and IgM antibodies Even so, a single negative antibody test does not rule out the diagnosis, because antibody levels can fluctuate. Repeat testing is sometimes needed.
A bone marrow examination is not always required, particularly in young children where the clinical picture is classic and the antibody test is positive. When it is performed, the typical finding is a marrow that is actively producing myeloid cells but with an apparent block in later maturation stages.12Hematology, Transfusion and Cell Therapy. PRIMARY AUTOIMMUNE NEUTROPENIA IN ADULTS: DIAGNOSTIC AND THERAPEUTIC CHALLENGES This pattern helps distinguish autoimmune neutropenia from conditions like congenital severe neutropenia or aplastic anemia, where the marrow itself is the primary problem. In adults, the workup also needs to rule out underlying systemic autoimmune diseases, drug causes, and lymphoproliferative disorders.
Treatment and Management
Because most patients, particularly children, do well despite their low counts, the first-line approach is often simply observation with supportive care.13Blood. How I treat autoimmune neutropenia in adults Good dental hygiene, prompt attention to fevers, and common-sense infection avoidance measures form the baseline. Prophylactic antibiotics have been shown in some series to nearly eliminate infections altogether during the active phase of the disease.14PubMed. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course
When treatment is needed, whether because of recurrent infections or a planned surgery requiring a higher neutrophil count, granulocyte colony-stimulating factor (G-CSF) is the go-to option. G-CSF is a growth factor that stimulates the bone marrow to produce neutrophils faster and release them into the bloodstream. In autoimmune neutropenia, it is effective at raising counts, and once a good response is achieved, the dose and frequency can typically be tapered down to just a couple of injections per week.15PubMed. Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF)
Steroids such as prednisone have been tried, and early reports showed they can temporarily suppress the antibodies and boost neutrophil counts. However, the effect is often fleeting. One early case described a child whose neutrophils normalized on steroids, only to drop again once the antibody titer climbed back despite continued steroid therapy.16New England Journal of Medicine. Chronic autoimmune neutropenia due to anti-NA2 antibody For that reason, steroids are not considered a reliable long-term solution.
For refractory cases, particularly in adults, immunosuppressive drugs and biologic agents enter the picture. Cyclosporine has been used successfully in patients who failed steroids alone.17Haematologica. Successful treatment of chronic autoimmune neutropenia with cyclosporin A Rituximab, which depletes the B cells responsible for making the offending antibodies, has shown encouraging results as well. In one case series, seven of eight patients achieved a complete or partial response to rituximab, and those who relapsed responded again to a second course.18PubMed Central. A Case of Autoimmune Neutropenia That Responded to Rituximab These heavier-duty options are reserved for the minority who have genuinely troublesome disease.
Triggers and Contributing Factors
What sets off the immune system’s attack on neutrophils in the first place is not fully understood, but several factors have been identified. Viral infections appear to play a triggering role in at least some childhood cases. Research examining bone marrow from children with chronic neutropenia found evidence of parvovirus B19 infection in the majority of patients tested, and most of those children also had antineutrophil antibodies.19PubMed. Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies Parvovirus B19 is the virus behind “fifth disease,” a common childhood rash illness, and autoimmune neutropenia is a recognized complication of infection with it.20PubMed. Parvovirus B19 infection and autoimmune disease The thinking is that the virus may alter neutrophil surface proteins or provoke an immune response that cross-reacts with normal neutrophil antigens.
Medications are another important trigger, particularly in adults. Certain drugs can provoke antibody formation against neutrophils through several proposed mechanisms: the drug or one of its breakdown products may attach to the neutrophil surface, creating a new target the immune system recognizes as foreign.21Immunohematology. Drug-induced immune neutropenia/agranulocytosis Beta-lactam antibiotics (the family that includes penicillins and cephalosporins) are among the more commonly implicated drugs, and both direct toxicity and immune mechanisms have been proposed to explain how they damage neutrophil production or survival.22PubMed. A Review of β-Lactam-Associated Neutropenia and Implications for Cross-reactivity Drug-induced immune neutropenia is technically a separate entity from primary autoimmune neutropenia, but the boundary between the two is blurry when a drug triggers a self-sustaining autoimmune response.
On the genetic side, variations in the genes encoding Fc-gamma receptors, the very surface proteins that the antibodies target, influence susceptibility. A Danish study found that children with certain copy-number and variant combinations in the FCGR gene cluster, including having only one copy of the gene for FcγRIIIb, had a higher risk of developing autoimmune neutropenia.23PubMed. Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort This makes biological sense: if the receptor protein on neutrophils is structurally slightly different due to a genetic variant, the immune system may be more likely to misrecognize it as foreign.
Primary Versus Secondary Versus Drug-Induced
The terminology can be confusing, so it helps to think of autoimmune neutropenia as a spectrum with three main categories. Primary autoimmune neutropenia is the standalone childhood form. It develops without any identifiable underlying disease, resolves on its own, and requires little or no treatment. Secondary autoimmune neutropenia arises in the context of another autoimmune or lymphoproliferative condition and tracks with the severity of that underlying disease. And drug-induced immune neutropenia results from a medication provoking an immune attack on neutrophils; it usually resolves once the offending drug is stopped, though recovery can take days to weeks.
The distinction matters practically because the treatment strategy differs. In primary childhood cases, you wait and watch. In secondary cases, you treat the underlying disease. In drug-induced cases, you stop the drug and provide supportive care. Alloimmune neonatal neutropenia, which occurs when a mother’s antibodies cross the placenta and attack the baby’s neutrophils (similar to Rh disease with red blood cells), is yet another distinct entity with its own timeline and management.24PubMed. Immune neutropenias of infancy and childhood
Why Counts Can Be Misleading
One of the most clinically relevant aspects of autoimmune neutropenia is the poor correlation between neutrophil count and infection risk. In many forms of neutropenia, particularly those caused by chemotherapy or bone marrow failure, a count below 500 cells per microliter signals serious danger. In autoimmune neutropenia, children routinely walk around with counts that low and fight off infections almost normally.
Part of the explanation lies in the bone marrow’s compensatory activity. Even though circulating neutrophils are being destroyed, the marrow is cranking out replacements. Some of these cells may be mobilized during an infection, temporarily boosting the count right when it matters most. The French pediatric study documented this phenomenon directly: while neutrophils were below 500 in over half of infection episodes, about a quarter of episodes saw counts bounce up to normal levels during the illness itself.25Archives of Disease in Childhood. Analysis of infectious complications in paediatric autoimmune neutropenia: a French nationwide retrospective cohort study The body seems able to push neutrophils into the bloodstream when an acute threat arises, even when the baseline count is very low.
This dynamic reserve is one reason why many hematologists feel comfortable watching and waiting rather than treating aggressively. It also explains the French study’s striking finding that despite a high hospitalization rate (71% of infection episodes led to admission), the hospitalizations were brief, with a median stay of about three days, and largely driven by clinical caution rather than genuine severity.
Living With the Diagnosis
For parents of children diagnosed with autoimmune neutropenia, the period between diagnosis and resolution can be stressful. The child appears healthy, but every sniffle raises the question of whether this is the time a dangerous infection might develop. Clinicians generally advise families to monitor for fevers and seek medical attention promptly, while reassuring them that the vast majority of infections will be the same minor illnesses all children get.
Practical measures make a difference. Good oral hygiene is recommended because the mouth is a common entry point for bacteria, and gum infections and mouth sores are among the more typical complications in neutropenic patients. Children can attend daycare and school normally in most cases, though individual guidance depends on the severity and frequency of infections. Routine childhood vaccinations should generally continue on schedule, since the immune defect in autoimmune neutropenia is limited to neutrophils and does not affect the antibody responses that vaccines rely on.
Adults with secondary autoimmune neutropenia face different challenges. Their neutropenia is part of a larger autoimmune picture, and management involves balancing treatments for the primary disease with the need to maintain adequate neutrophil counts. Immunosuppressive medications used for conditions like lupus or rheumatoid arthritis can themselves cause neutropenia as a side effect, creating a complicated situation where the treatment for the underlying disease overlaps with one of its complications. Close monitoring with regular blood counts is standard in these patients, and the threshold for starting G-CSF or adjusting immunosuppression varies by clinical context.
When Antibody Testing Falls Short
Detecting antineutrophil antibodies would seem like a straightforward way to confirm the diagnosis, but in practice, testing is notoriously imperfect. Neutrophils are difficult cells to work with in the lab: they die quickly, release enzymes that interfere with assays, and can activate spontaneously during processing. Standard indirect tests, which look for free antibodies in the patient’s serum, have limited sensitivity because the antibody may be mostly bound to neutrophils rather than floating free in the blood. Direct tests, which look for antibodies already stuck to the patient’s own neutrophils, perform better but require fresh cells handled carefully.26PubMed. Diagnosis of autoimmune neutropenia by neutrophil-bound IgG and IgM antibodies
Because of these technical limitations, the diagnosis is sometimes made on clinical grounds: an otherwise healthy young child with isolated neutropenia, no concerning bone marrow findings, and a benign infection history is presumed to have autoimmune neutropenia even if antibody testing is inconclusive. The response to the passage of time, a gradual normalization of counts over months to a couple of years, ultimately confirms the diagnosis retrospectively. For adults, where the differential diagnosis is broader, the workup tends to be more exhaustive, and a negative antibody test carries more weight in redirecting the investigation toward other causes.